Diagnostic and Therapeutic Use of Human Recombinant Thyrotropin (rhTSH)(Thyrogen®) in Well-Differentiated Thyroid Cancer - Current Indications and Future Perspectives - A Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-676x|6|1|1-14

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.6, Iss.1, 2010-02, pp. : 1-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Annual financial impact of well-differentiated thyroid cancer care in the United States

By Lubitz Carrie C.   Kong Chung Y.   McMahon Pamela M.   Daniels Gilbert H.   Chen Yufei   Economopoulos Konstantinos P.   Gazelle G. Scott   Weinstein Milton C.  

Cancer, Vol. 120, Iss. 9, 2014-05 ,pp. : 1345-1352

Blackwell Publishing

Access to resources Recommend Favorite

The therapeutic management of differentiated thyroid cancer

By Sipos Jennifer A   Mazzaferri Ernest L  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2627-2637

Informa Healthcare

Access to resources Recommend Favorite

Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives

By  

Current Medicinal Chemistry, Vol. 23, Iss. 36, 2016-11 ,pp. : 4135-4150

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives

By Cattaneo Dario   Baldelli Sara   Merlini Simona   Zenoni Stefania   Perico Norberto   Remuzzi Giuseppe  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1553-1566

Informa Healthcare

Access to resources Recommend Favorite

Clinical uses of recombinant human thyrotropin

By Gourgiotis Loukas   Skarulis Monica C  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2503-2514

Informa Healthcare

Access to resources Recommend Favorite